Next Article in Journal
Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature
Next Article in Special Issue
Ochratoxin A: Molecular Interactions, Mechanisms of Toxicity and Prevention at the Molecular Level
Previous Article in Journal
Gastrointestinal Degradation of Fumonisin B1 by Carboxylesterase FumD Prevents Fumonisin Induced Alteration of Sphingolipid Metabolism in Turkey and Swine
Previous Article in Special Issue
Ochratoxin A Producing Fungi, Biosynthetic Pathway and Regulatory Mechanisms
Article Menu
Issue 4 (April) cover image

Export Article

Open AccessArticle
Toxins 2016, 8(4), 87;

Maternal-Fetal Cancer Risk Assessment of Ochratoxin A during Pregnancy

School of Biological Sciences, Faculty of Science, Kadoorie Biological Sciences Building, The University of Hong Kong, Pokfulam, Hong Kong, China
Author to whom correspondence should be addressed.
Academic Editors: Richard A. Manderville and Annie Pfohl-Leszkowicz
Received: 27 January 2016 / Revised: 16 March 2016 / Accepted: 17 March 2016 / Published: 23 March 2016
(This article belongs to the Collection Ochratoxins-Collection)
Full-Text   |   PDF [279 KB, uploaded 23 March 2016]   |  


Increasing evidence has demonstrated that in utero exposure to environmental chemicals may interfere with fetal development and increase the risk of disease and cancer development later in life. Ochratoxin A (OTA) has been proven to induce diverse toxic effects including teratogenicity, carcinogenicity, immunotoxicity and potential endocrine disruption. Due to the continuous and widespread occurrence of OTA as a potential contaminant of staple foods, there is increasing concern of in utero exposure of fetus to this mycotoxin. In this study, maternal-fetal risk assessment of OTA during pregnancy was conducted using the benchmark dose approach for genotoxic carcinogens. The daily intake of OTA for Egyptian pregnant women was estimated based on their serum OTA level using the refined Klaassen equation for pregnancy. Fetal exposure level was also estimated based on the maternal data. Comparison between the estimated daily exposure and the negligible cancer risk intake (NCRI), and the calculation of margin of exposure (MOE) implicated that OTA exposure from dietary intake would be of low health concern for this general subpopulation of Egyptian women. This subpopulation of pregnant women was generally estimated not to be in high-risk for toxicity induced by OTA. View Full-Text
Keywords: Ochratoxin A; risk assessment; mycotoxin; fetal; pregnancy Ochratoxin A; risk assessment; mycotoxin; fetal; pregnancy

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Woo, C.S.J.; El-Nezami, H. Maternal-Fetal Cancer Risk Assessment of Ochratoxin A during Pregnancy. Toxins 2016, 8, 87.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top